Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four ...

The current US Commerce Secretary - Howard Luttnick - has once again targeted Ireland, calling our country his 'favourite tax ...

Johnson & Johnson announced they will invest $55 billion over a four-year period to build manufacturing facilities in the ...

And the shock from Trump’s change in attitude has terrified ... Jim Cramer in a latest program on CNBC called Eli Lilly And Co (NYSE:LLY) sellers “uninformed” and urged investors to look ...

The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024. The Nasdaq Composite ...

After Trump threatened 25% tariffs on pharma imports, J&J became the latest pharma company to announce investments in the U.S.

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

Johnson & Johnson will invest $55 billion in the U.S. over the next four years. The announcement comes a month after Eli ...